Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
DOJ
300 Drugs Now Under Investigation in “Generic Drug Cartel”
What began at the end of 2016 as an antitrust lawsuit has now exploded into an investigation of alleged price-fixing involving at…
Government Intervenes in Select Few Qui Tam Suits
Mintz Levin recently reviewed unsealed healthcare-related qui tam cases in early 2018, identifying a total of forty-six cases…
AmerisourceBergen Resolves Civil Fraud Charges, Agrees To Pay $625 Million
On Monday, October 1, 2018, the United States Department of Justice (DOJ) announced a $625 million agreement to resolve civil…
AstraZeneca Agrees to Settle Off-Label Marketing Suits
Recently, AstraZeneca Plc agreed to pay $110 million to settle two Texas claims that alleged the company cheated Texas’ Medicaid…
United States Joins Lawsuit Over Suboxone
Recently, the Department of Justice (DOJ) filed to join whistleblower lawsuits against Indivior Plc and Reckitt Benckiser Group…
AngioDynamics Settles False Claims Act Allegations for $12.5 Million
In July 2018, medical device manufacturer AngioDynamics, Inc., agreed to pay the United States $12.5 million to resolve…
Consultant Found Guilty Using CMS Data for Insider Trading
Washington, D.C. based consultant David Blaszczak was convicted and found guilty of stealing secrets from the government and…
Insys: The Hits, They Just Keep Coming – One Rep Pleads Guilty to…
We have previously written about Insys founder John Kapoor and other executives that have found themselves in hot water regarding…
Pfizer Pays Millions to Resolve Co-Pay Allegations – Settlement and…
On Thursday, May 24, 2018, Pfizer, Inc., agreed to pay $23.85 million to resolve claims that it used a foundation as a conduit to…
Alere Settles False Claims Act Allegations for $33.2 Million
Massachusetts-based medical device manufacturer Alere (acquired by Abbott Laboratories in 2017) and its subsidiary Alere San Diego…